multiple sclerosis m onset childhood offer unique opportun studi infect background disease immune reaction agent child recent investing epidemiology studi strongly italic involve one aetiolog epsteinbarr virus eb prime candid rather actual caps probably involve develop immunoregulatori pathway disturb hygienerel factor include alter sequence infect may genre maintain deficit within immunology network facility particular early event priced year dead framework serv guid immunology molecular biology investing formal approach shed light complex natur history lead ration prevent therapeutic strategy possible future could prevent vaccine elev design appropri type vaccine 